Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2002-7-24
pubmed:abstractText
The common genetic G to A variation of the prothrombin gene is associated with elevated levels of prothrombin [factor II (FII)] and is recognized as a risk factor for thrombosis. To determine whether one type of assay for plasma FII measurement was more efficient than other assays in displaying high FII levels in 20210A carriers, we compared five methods of measuring FII levels [i.e. an enzyme-linked immunosorbent assay (ELISA), a standard clotting assay, and three chromogenic methods using three different activators: Ecarin, Oxyuranus, and Textarin] in 30 G20210A patients and 30 G20210G controls. Plasma concentrations of factor X and factor VII + factor X were also determined by a clotting procedure. Functional assays were found to be equally efficient in demonstrating significantly higher FII levels in 20210A carriers than in non-carriers (P < 0.0001). With ELISA, the difference observed was less significant (P < 0.005). The specificity of every assay increased with FII cut-off levels; when a cut-off of 115% was applied, sensitivities of functional assays were between 73 and 93%, while sensitivities of ELISA declined dramatically to 33%. FII/factor X and FII/factor VII + factor X ratios were significantly higher in 20210A carriers (P < 0.0001). In conclusion, functional assays are preferentially required for measurements of FII levels in carriers of the 20210A variant.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0957-5235
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
465-70
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12138376-3' Untranslated Regions, pubmed-meshheading:12138376-Adolescent, pubmed-meshheading:12138376-Adult, pubmed-meshheading:12138376-Aged, pubmed-meshheading:12138376-Aged, 80 and over, pubmed-meshheading:12138376-Area Under Curve, pubmed-meshheading:12138376-Blood Coagulation Tests, pubmed-meshheading:12138376-Child, pubmed-meshheading:12138376-Child, Preschool, pubmed-meshheading:12138376-Chromogenic Compounds, pubmed-meshheading:12138376-Elapid Venoms, pubmed-meshheading:12138376-Endopeptidases, pubmed-meshheading:12138376-Enzyme Activation, pubmed-meshheading:12138376-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:12138376-Factor VII, pubmed-meshheading:12138376-Factor X, pubmed-meshheading:12138376-Female, pubmed-meshheading:12138376-Genotype, pubmed-meshheading:12138376-Humans, pubmed-meshheading:12138376-Male, pubmed-meshheading:12138376-Middle Aged, pubmed-meshheading:12138376-Polymorphism, Genetic, pubmed-meshheading:12138376-Prothrombin, pubmed-meshheading:12138376-ROC Curve, pubmed-meshheading:12138376-Sensitivity and Specificity, pubmed-meshheading:12138376-Serine Endopeptidases, pubmed-meshheading:12138376-Thrombophilia
pubmed:year
2002
pubmed:articleTitle
Comparative evaluation of five different methods for the measurement of plasma factor II levels in carriers of the 20210A prothrombin variant.
pubmed:affiliation
Laboratory of Hematology, Trousseau Hospital, Tours Cedex, France.
pubmed:publicationType
Journal Article, Comparative Study